Liqvor to invest 7.6 billion drams in production of eye drops
06.02.2019,
16:15
The government of Armenia exempted today the pharmaceutical company Liqvor from payment of customs duties on the import of equipment and raw materials after it pledged to invest 7.624 billion drams in the expansion of the production of eye drops.
YEREVAN, February 6. /ARKA/. The government of Armenia exempted today the pharmaceutical company Liqvor from payment of customs duties on the import of equipment and raw materials after it pledged to invest 7.624 billion drams in the expansion of the production of eye drops.
Economic Development and Investments Minister Tigran Khachatryan said the company is engaged in the production of medicines and drugs and the benefits will allow it to implement a new investment program and create new jobs.
He said for the expansion of production in Yerevan the company will import equipment and raw materials in the amount of 12.9 billion drams and will create 8 new jobs with an average salary of 75,500 drams ($155).
According to the minister, the company is expected to produce annually 13 billion drams worth medicines, of which 3.8 billion drams will be sold in Armenia, 1 billion drams in Russia and several other countries, which are members of the Eurasian Economic Union and 8 billion drams worth medicines will be exported to other countries.
Liqvor, established in 19991 is a privately owned pharmaceutical producer. It was the first to achieve Good Manufacturing Practice certificate in the South Caucasus. Liqvor became the first private pharmaceutical company in Armenia and then also the first in the CIS to manufacture infusion solutions in plastic packaging according to European standards.
The company produces 60 names of infusion, injection, ophthalmic, hemostatic and otorhinolaryngological preparations and exports its products to almost all CIS countries. ($ 1 - AMD 487.65). -0-
Economic Development and Investments Minister Tigran Khachatryan said the company is engaged in the production of medicines and drugs and the benefits will allow it to implement a new investment program and create new jobs.
He said for the expansion of production in Yerevan the company will import equipment and raw materials in the amount of 12.9 billion drams and will create 8 new jobs with an average salary of 75,500 drams ($155).
According to the minister, the company is expected to produce annually 13 billion drams worth medicines, of which 3.8 billion drams will be sold in Armenia, 1 billion drams in Russia and several other countries, which are members of the Eurasian Economic Union and 8 billion drams worth medicines will be exported to other countries.
Liqvor, established in 19991 is a privately owned pharmaceutical producer. It was the first to achieve Good Manufacturing Practice certificate in the South Caucasus. Liqvor became the first private pharmaceutical company in Armenia and then also the first in the CIS to manufacture infusion solutions in plastic packaging according to European standards.
The company produces 60 names of infusion, injection, ophthalmic, hemostatic and otorhinolaryngological preparations and exports its products to almost all CIS countries. ($ 1 - AMD 487.65). -0-
